Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Children's Hospital Los Angeles has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners and 3 distinct art units, indicating separate assignment paths across both categories.
KREMER, MATTHEW is the busiest examiner, with 1 pending matter. The docket is better suited to matter-by-matter review than to relying on a recurring examiner or art-unit practice. Counsel can still maintain consistent terminology and disclosure positions across the biotechnology portfolio while tailoring each response to its assigned examination context.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KREMER, MATTHEW | 1 | 43.6% | +52.2% |
| MOORE, JOHN DAVID | 1 | 61.1% | +28.3% |
| CORDAS, EMILY ANN | 1 | 50.9% | +57.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18559119 | Methods for Making Stem Cell-Derived Enteric Neural Crest Cells and Their Use in Enteric Neuropathy Treatment | MOORE, JOHN DAVID | 33d |
| 18997110 | SYSTEMS AND METHODS FOR DETECTING PATHOLOGIC BREATHS/BREATHING PATTERNS | KREMER, MATTHEW | — |
| 17620603 | BCL11B Overexpression to Enhance Human Thymopoiesis and T Cell Function | CORDAS, EMILY ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18559119 | Methods for Making Stem Cell-Derived Enteric Neural Crest Cells and Their Use in Enteric Neuropathy Treatment | MOORE, JOHN DAVID | 33d |
| 18997110 | SYSTEMS AND METHODS FOR DETECTING PATHOLOGIC BREATHS/BREATHING PATTERNS | KREMER, MATTHEW | — |
| 17620603 | BCL11B Overexpression to Enhance Human Thymopoiesis and T Cell Function | CORDAS, EMILY ANN | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| 1638 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18997110 | SYSTEMS AND METHODS FOR DETECTING PATHOLOGIC BREATHS/BREATHING PATTERNS | KREMER, MATTHEW | 3791 | §101§103§112 | Non-Final OA | — | Pending | Jan 20, 2025 |
| 18559119 | Methods for Making Stem Cell-Derived Enteric Neural Crest Cells and Their Use in Enteric Neuropathy Treatment | MOORE, JOHN DAVID | 1638 | §102§103 | Final Rejection | 33d | Pending | Nov 06, 2023 |
| 17620603 | BCL11B Overexpression to Enhance Human Thymopoiesis and T Cell Function | CORDAS, EMILY ANN | 1632 | §103§112 | Final Rejection | — | Pending | Dec 17, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChildren's Hospital Los Angeles has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Matthew Kremer has the most, with 1 of Children's Hospital Los Angeles's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
